ZA200200280B - Mycophenolate mofetil in association with PEG-IFN-alpha. - Google Patents

Mycophenolate mofetil in association with PEG-IFN-alpha.

Info

Publication number
ZA200200280B
ZA200200280B ZA200200280A ZA200200280A ZA200200280B ZA 200200280 B ZA200200280 B ZA 200200280B ZA 200200280 A ZA200200280 A ZA 200200280A ZA 200200280 A ZA200200280 A ZA 200200280A ZA 200200280 B ZA200200280 B ZA 200200280B
Authority
ZA
South Africa
Prior art keywords
ifn
peg
alpha
association
mycophenolate mofetil
Prior art date
Application number
ZA200200280A
Inventor
Mary Catherine Graves
Friederike Zahm
Stephen Chris Pappas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA200200280B publication Critical patent/ZA200200280B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA200200280A 1999-08-13 2002-01-11 Mycophenolate mofetil in association with PEG-IFN-alpha. ZA200200280B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99115950 1999-08-13

Publications (1)

Publication Number Publication Date
ZA200200280B true ZA200200280B (en) 2003-04-11

Family

ID=29762814

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200200280A ZA200200280B (en) 1999-08-13 2002-01-11 Mycophenolate mofetil in association with PEG-IFN-alpha.

Country Status (14)

Country Link
EP (1) EP1220683A2 (en)
JP (1) JP2003507339A (en)
CN (1) CN1368887A (en)
AU (1) AU7408200A (en)
BR (1) BR0013252A (en)
CA (1) CA2380653A1 (en)
HU (1) HUP0202525A3 (en)
MX (1) MXPA02001296A (en)
PE (1) PE20010490A1 (en)
PL (1) PL357367A1 (en)
RU (1) RU2002105485A (en)
TR (1) TR200200401T2 (en)
WO (1) WO2001012214A2 (en)
ZA (1) ZA200200280B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307553D0 (en) * 2003-04-01 2003-05-07 Novartis Ag Organic compounds
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
SI1719773T1 (en) 2004-02-24 2009-08-31 Japan Tobacco Inc Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
US7632491B2 (en) * 2004-08-12 2009-12-15 Schering Corporation Stable pegylated interferon formulation
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
US8017612B2 (en) 2006-04-18 2011-09-13 Japan Tobacco Inc. Piperazine compound and use thereof as a HCV polymerase inhibitor
WO2010110503A1 (en) * 2009-03-27 2010-09-30 주식회사 중외제약 INTERFERON-α (IFN-α) FUSED PROTEIN HAVING IFN-α AND CYTOPLASMIC TRANSDUCTION PEPTIDE (CTP)
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
DE202012013117U1 (en) 2011-10-21 2015-01-16 Abbvie Inc. Combination treatment (e.g., with ABT-072 or ABT-333 from DAAs for use in the treatment of HCV)
DE112012003510T5 (en) 2011-10-21 2015-03-19 Abbvie Inc. Method for the treatment of HCV comprising at least two direct-acting antiviral agents, ribavirin but not interferon
JP6820841B2 (en) * 2014-11-06 2021-01-27 ファーマエッセンティア コーポレイション Dosing regimen for pegged interferon
CN109689063A (en) 2016-04-28 2019-04-26 埃默里大学 Nucleotide containing alkynes and nucleosides therapeutic combination and its associated uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908621A (en) * 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
MY125300A (en) * 1999-02-26 2006-07-31 Inst Of Molecular And Cell Biology Synergistic combination for treatment of viral-mediated diseases

Also Published As

Publication number Publication date
MXPA02001296A (en) 2002-07-22
PL357367A1 (en) 2004-07-26
CN1368887A (en) 2002-09-11
WO2001012214A3 (en) 2001-10-04
TR200200401T2 (en) 2002-06-21
WO2001012214A2 (en) 2001-02-22
RU2002105485A (en) 2004-01-27
EP1220683A2 (en) 2002-07-10
JP2003507339A (en) 2003-02-25
AU7408200A (en) 2001-03-13
PE20010490A1 (en) 2001-04-27
BR0013252A (en) 2002-04-16
CA2380653A1 (en) 2001-02-22
HUP0202525A3 (en) 2003-11-28
HUP0202525A2 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
ZA200107409B (en) Fuel composition.
GB2349180B (en) Inverted I.C.engine configuration
HK1069913A1 (en) Generalized text localization in images.
MXPA01013362A (en) ANTI-alphav.
ZA200110370B (en) Warp-tied composite forming fabric.
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
ZA200200477B (en) 2-pyrazolin-5-ones.
ZA200202537B (en) Pour-on-formulations.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
MXPA02002209A (en) Container with message.
ZA200200280B (en) Mycophenolate mofetil in association with PEG-IFN-alpha.
ITRE990028A0 (en) CHELATED FOOD SUPPLEMENT FOR AGRO-ZOOTECHNICAL USE, AND METHOD FOR OBTAINING THE SAME.
HK1032814A1 (en) Absorber.
IL147612A0 (en) MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PREG-IFN-α
ZA200005803B (en) Personal Watercraft Engine.
GB0029720D0 (en) I.S machine7544232001
ZA992018B (en) Banners.
MXPA03003525A (en) Scaleable wormhole-routing concentrator.
Lysenko et al. Maliariologiia
Tucker Santamarian 1999
Larsson-Kråik Fullskalig testrigg: förstudie
Starčević et al. Milanković juče danas sutra
Funder Deconstructing Philosophy
Avaghade Solapur shahratil 2 staravar adhypan karnarya shikshkanchya adhyapanatil samsyancha chikitsak abhyas
Root Santamarian 2000